US Breast Cancer Lumpectomy Market Treatment Cost and Opportunity Analysis 2024

Download Sample

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink: https://www.kuickresearch.com/report-us-breast-cancer-lumpectomy-market,-treatment-cost-and-opportunity-analysis-2024.php

Table of Contents

1. Prologue to Breast Cancer and Lumpectomy
1.1 Lumpectomy - A Breast Conserving Strategy
1.2 A Safer and Efficient Alternative to Mastectomy

2. Lumpectomy - Opportunities in the US Breast Cancer Therapy Market
2.1 US Breast Cancer Market Size
2.2 Increasing Breast Cancer Incidence in the US
2.3 Combination of Lumpectomy and Radiation - Equivalent Efficacy to Mastectomy
2.3.1 Mastectomy v/s Lumpectomy Preference in American Women
2.3.2 Overall Survival and Recurrence Rates

3. Lumpectomy - Procedure and Cost Involved
3.1 Breast Cancer Mammogram and Biopsy Cost
3.2 Cost Involved During the Procedure
3.2.1 Lumpectomy plus Whole-Breast Radiation Therapy
3.2.2 Lumpectomy plus Partial-Breast Radiation Therapy (Brachytherapy)
3.3 Lumpectomy and Mastectomy Reimbursement Analysis
3.4 Post Lumpectomy Costs
3.4.1 Mastectomy or Mastectomy Plus Reconstruction
3.4.2 Additional Cost (Consumable, Lab, Imaging and Other Service Cost)
3.5 Cost Effectiveness of Lumpectomy

4. Current Market Scenario and Trends in Lumpectomy Breast Cancer Treatment
4.1 Rise in Breast Cancer Screening among American Women
4.1.1 Entry of Advanced Breast Imaging Techniques
4.1.2 Rising Awareness Regarding Breast Cancer Screening
4.1.3 Breast Cancer Incidence and Lumpectomy Preference in Men
4.2 Rise in Clinical Studies Proving Better Efficacy of Lumpectomy

5. Lumpectomy Market Analysis by Technology
5.1 MarginProbe - An Intra Operative Technology to Improve Lumpectomy
5.2 Savi Scout-Breast Localization and Surgical Guidance System
5.3 Biozorb LP for Better Cosmetic Outcome after Lumpectomy

6. Key Developments Affecting the US Lumpectomy Market
6.1 Focus of Key Industries in Early Stage Breast Cancer Segment
6.2 Introduction of Better Breast Cancer Screening Technology and Its Impact on the Lumpectomy Market
6.3 Expansion of US Lumpectomy Technology and Products to Global Platforms
6.3.1 iCAD Early Breast Cancer Screening Technology
6.3.2 Intrabeam System by Carl Zeiss Meditech

7. New and Better Breast Imaging Technology Driving Lumpectomy Market
7.1 Digital Breast Tomosynthesis (DBT)
7.2 Breast Cancer Genetic Screening Tests on the Rise
7.3 FDA Approval of Innovative Lumpectomy Technology
7.4 Magnetic MaMaLoc Technology - Localized Lumpectomy Procedure

8. Presence of Venture Capitalist influencing the US Breast Cancer Lumpectomy Segment

9. Porter’s Five Force Analysis of the Breast Lumpectomy Market
9.1 Threat of New Entrant
9.2 Bargaining Power of Patient
9.3 Bargaining Power of Service Providers
9.4 Intensity of Competitive Rivalry
9.5 Threat of Substitutes Procedures

10. Lumpectomy Market Analysis by End User
10.1 Hospitals
10.2 Oncology Research and Screening Centers

11. US Lumpectomy Market Dynamics
11.1 Market Driving Parameters
11.2 Market Growth and Acceptability Challenges

12. Future Forecast and Projections of the Lumpectomy Market

13. Competitive Analysis
13.1 Carl Zeiss Meditech
13.2 Cianna Medical
13.3 Clear Cut Medical
13.4 Dune Medical Devices
13.5 Endomagnetics
13.6 Focal Therapeutics
13.7 Hologic
13.8 iCAD
13.9 Medtronic
13.10 Sanarus

Figure 1-1: Overview of Lumpectomy
Figure 1-2: Treatment Algorithm in Early Breast Cancer Patients
Figure 1-3: Global-Five Year Survival Rate in Breast Cancer by Stage
Figure 1-4: Lumpectomy v/s Mastectomy Overview
Figure 2-1: US v/s Rest of the World - Breast Cancer Market Size (%), 2018
Figure 2-2: US - Breast Cancer Prevalence and Incidence (Patients/Year), 2016-2018
Figure 2-3: US - Probability of Developing Breast Cancer in Women by Age(%), 2018
Figure 2-4: US - Probability of Breast Cancer by Ethnicity (%), 2018
Figure 2-5: Lumpectomy and Mastectomy - Estimated Market Size (%), 2018
Figure 2-6: US - Mastectomy v/s Lumpectomy Preference (%) , 2018
Figure 2-7: US - Five Year Survival Rate in Women (%), 2018
Figure 2-8: US - Five Year Survival Rate in Men (%), 2018
Figure 2-9: Efficacy of Lumpectomy v/s Mastectomy (%)
Figure 3-1: US - Lumpectomy Treatment Cost by Stage of Breast Cancer (US$/Patient), 2018
Figure 3-2: US - Lumpectomy Breast Surgery Cost (US$), 2018
Figure 3-3: Lumpectomy - General Overview of the Procedure
Figure 3-4: US - Mammogram Cost Analysis (US$/Test), 2018
Figure 3-5: US- Biopsy and Mammography Cost (US$/Patient), 2018
Figure 3-6: Recent Alternatives to Breast Cancer Biopsy
Figure 3-7: US - ONCOblot and Thermography Cost Analysis (US$), 2018
Figure 3-8: US - Whole Breast and Partial Breast Radiation Therapy Cost Analysis (US$), 2018
Figure 3-9: US - Average Lumpectomy plus Whole Breast Radiation Cost (US$), 2018
Figure 3-10: Intrabeam - Single Dose Radiation Therapy Cost Analysis (US$), 2018
Figure 3-11: US - Lumpectomy plus Breast Radiation Cost (US$), 2018
Figure 3-12: US - Mastectomy and Lumpectomy Reimbursement Analysis (US$), 2018
Figure 3-13: US - Breast Reconstruction Surgery Cost (US$), 2018
Figure 3-14: US - Breast Reconstruction Cost Post Lumpectomy (US$), 2018
Figure 3-15: US - Average Consumable, Lab and Additional Service Cost in Lumpectomy (US$/Patient), 2018
Figure 3-16: Comparative Cost Analysis of Mastectomy and Lumpectomy (US$), 2018
Figure 4-1: US - USPTF Estimated Screening Cost (US$ Billion)
Figure 4-2: US - Digital Mammography System Equipment Cost (US$), 2018
Figure 4-3: US - Epidemiology (Estimate) of Breast Cancer by Gender, 2018
Figure 5-1: Marginprobe - A Recent Advancement in the Lumpectomy Segment
Figure 5-2: MargineProbe - Clinical Efficacy Data proving it Efficacy (%), 2018
Figure 5-3: MarginProbe - Breast Re-Excision Reduction Rate (%), 2018
Figure 5-4: Savi Scout - Feature Overview
Figure 6-1: Sentimag - Key Features in Lumpectomy
Figure 6-2: Intrabeam - An Insight into its Key Features
Figure 6-3: US v/s Rest of the World-Intrabeam Centers (Number), 2018
Figure 7-1: Advantages of Novel Breast Tomography Technique over 2D Technology
Figure 7-2: Magnetic MaMaLoc Technology - Overview
Figure 8-1: US - Emerging Markets Affecting the Lumpectomy Segment
Figure 9-1: US - Lumpectomy Marker - Porter's Five Force Analysis
Figure 10-1: US - Recommended Frequency of Breast Cancer Screening by Age
Figure 10-2: US - Lumpectomy Market Size by End User (%), 2018
Figure 10-3: US - Out Patient Department Visits for Breast Cancer (Patients/State), 2017
Figure 10-4: US - Lumpectomy and Mastectomy Payment Source Analysis by Patients (Number), 2017
Figure 10-5: US - Cancer Research Funds across Major Research Centers (US$ Million), 2017
Figure 11-1: Driving Factors of the Lumpectomy Market
Figure 11-2: US - Lumpectomy Market Challenges
Figure 12-1: US - Lumpectomy Market Future Forecast (US$ Billion), 2017-2024

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.